Navigation Links
Clinical Intervention Eliminates Heel Ulcer Incidents in ICU
Date:3/3/2009

- Texas medical center reduces heel ulcers to zero, saves nearly $2 million

CARY, Ill., March 3 /PRNewswire/ -- Intensive Care Unit (ICU) patients that are sedated or immobilized are at a higher risk for the development of heel pressure ulcers and plantar flexion contractures, conditions that can significantly reduce quality of life. Establishment of a heel ulcer prevention protocol including the use of heel protectors resulted in 100 percent prevention of hospital-acquired heel pressure ulcers and plantar flexion contractures, according to findings presented February 27 and 28 at the biennial conference for the National Pressure Ulcer Advisory Panel (NPUAP). The NPUAP helps shape public policy through education and research in order to improve patient outcomes.

"Preventing heel pressure ulcers by applying a protocol such as a heel protector device can have an immediate impact on at-risk patients," said Tina Meyers, WOC Program Manager at Harris County Hospital District in Harris County, TX and lead investigator of the study. "The preventative approach represents a shift in the clinical paradigm from other traditional methods."

In the study, 53 sedated ICU patients from Conroe Regional Medical Center in Conroe, TX were given a heel protector to maintain heel suspension and prevent plantar flexion contracture. The prevention protocol included pressure ulcer risk identification, early recognition of skin issues, and methods to maintain proper heel alignment and suspension.

After a 7-month assessment, none of the patients developed new pressure ulcers or skin injury, and 9.4% of patients showed improvement in heel status from entry to discharge. In addition, of the 16 abnormal heels upon entry, only 8 heels were abnormal upon exit, representing a 50% decrease of abnormal heel status.

The study also estimated a significant cost savings for the hospital. Upon evaluation of the cost of a heel protector compared to treatment costs for heel ulcers the hospital realized an annual cost-savings of approximately $1.9 million. The heel protector device utilized in this study is the Prevalon(R) Pressure-Relieving Heel Protector, manufactured by Sage Products.

Recent healthcare reform has put additional focus on ulcer prevention in ICUs. In the last year, the Centers for Medicare and Medicaid Services (CMS) stopped providing reimbursement for hospital-acquired pressure ulcers. The CMS guidelines, along with research, are further increasing awareness for a preventative approach to patient care.

About Sage Products Inc.

Since 1971, Sage Products has developed disposable healthcare products trusted by leading healthcare facilities worldwide. The company has a core belief in prevention--that evidence-based interventions improve outcomes. Sage is pioneering Interventional Patient Hygiene with industry-leading brands such as Toothette(R) oral care, Sage(R) 2% Chlorhexidine Gluconate Cloths for patient preoperative skin preparation, Comfort Bath(R) Cleansing Washcloths, Comfort Shield(R) Incontinence Care Washcloths and Prevalon(R) Pressure-Relieving Heel Protector. These advanced hygiene products make it easier for busy nurses to deliver essential patient care. The company's goal is to help improve patient safety and outcomes by preventing skin breakdown, healthcare-associated pneumonias, surgical site infections and other adverse hospital-acquired events. For more information, visit www.sageproducts.com.


'/>"/>
SOURCE Sage Products Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Radiologists encouraged to look beyond cancer for clinically unseen diseases
2. Clinical depression linked to abnormal emotional brain circuits
3. Preclinical study suggests organ-transplant drug may aid in lupus fight
4. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
5. Good Clinical Practice Journal Awards: Winners Announced
6. Microsoft Helps Developers of Clinical User Interfaces Improve Efficiency, Patient Safety With Free Toolkit
7. Study Questions Dead-End Cancer Clinical Trials
8. Genomic Health Announces Multiple Studies on Oncotype DX(TM) Presented at 2007 American Society of Clinical Oncology (ASCO) Breast Cancer Symposium
9. Clinical trials present better alternatives for dialysis patients
10. Mirixa Debuts New Clinical Technology Solutions for Enhancing Patient Care
11. IMPACT initiative looks to improve patient participation in clinical trials
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... June 19, ... the dangers associated with chronic pain and the benefits of holistic treatments, Serenity ... who are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg Traurig, ... Elite. The attorneys chosen by their peers for this recognition are considered among the ... Traurig Shareholders received special honors as members of this year’s Legal Elite Hall of ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway ... call for a minimum wage raise to $12 an hour by 2020 and then adjusting ... restore the lost value of the minimum wage, assure the wage floor does not erode ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... Living, is proud to recognize Dr. Barry M. Weintraub as a prominent plastic ... most beautiful women in the world, and the most handsome men, look naturally ...
(Date:6/24/2016)... ... June 24, 2016 , ... National recruitment firm Slone ... executive with extensive sequencing and genomics experience, as Vice President of North American Capital ... will be responsible for leading the sales team in the commercialization of the HTG ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... Research and Markets has announced the ... report to their offering. ... favourable commercial environment for MedImmune to enter. The US ageing ... serve to drive considerable growth for effective anti-influenza medications. The ... sales considerably, but development is still in its infancy. ...
(Date:6/23/2016)... RIDGE, Ill. and INDIANAPOLIS ... of students receiving a Lilly Diabetes Tomorrow,s Leaders Scholarship ... The 2016 scholarship winners, announced today online at ... to let type 1 diabetes stand in the way ... Diabetes has supported the Foundation,s scholarship program since 2012, ...
(Date:6/23/2016)... N.J. , June 23, 2016  Guerbet announced ... Premier Inc.,s Supplier Horizon Award . ... year, Guerbet was recognized for its support of Premier ... creation through clinical excellence, and commitment to lower costs. ... to receive this recognition of our outstanding customer service ...
Breaking Medicine Technology: